Key result
Degenerative thoracic myelopathy encompasses interrelated clinical entities that present similarly, supporting the adoption of a unified nomenclature framework to improve recognition and research.
Why the study?
Thoracic myelopathy arises from several etiologies with similar presentation and management, leading to uncertainties in terminology and definitions.
Systematic Review
The study proposes the unifying term 'degenerative thoracic myelopathy' (DTM) to encompass various interrelated degenerative conditions of the thoracic spine, aiming to improve clinical recognition and research communication.
Answers are grounded in this paper and cite their sources.
Highlights persistent thoracic myelopathy uncertainties; leaves open whether DCM-style nomenclature advances research and care.
Study Design Literature Review. Objective Myelopathy affecting the thoracic spinal cord can arise secondary to several aetiologies which have similar presentation and management. Consequently, there are many uncertainties in this area, including optimal terminology and definitions. Recent collaborative cervical spinal research has led to the proposal and subsequent community adoption of the name degenerative cervical myelopathy(DCM), which has facilitated the establishment of internationally-agreed research priorities for DCM. We put forward the case for the introduction of the term degenerative thoracic myelopathy(DTM) and degenerative spinal myelopathy(DSM) as an umbrella term for both DCM and DTM. Methods Following PRISMA guidelines, a systematic literature search was performed to identify degenerative thoracic myelopathy literature in Embase and MEDLINE. Results Conditions encompassed within DTM include thoracic spondylotic myelopathy, ossification of the posterior longitudinal ligament, ossification of the ligamentum flavum, calcification of ligaments, hypertrophy of ligaments, degenerative disc disease, thoracic osteoarthritis, intervertebral disc herniation, and posterior osteophytosis. The classic presentation includes girdle pain, gait disturbance, leg weakness, sensory disturbance, and bladder or bowel dysfunction, often with associated back pain. Surgical management is typically favoured with post-surgical outcomes dependent on many factors, including the causative pathology, and presence of additional stenosis. Conclusion The clinical entities encompassed by the term DTM are interrelated, can manifest concurrently, and present similarly. Building on the consensus adoption of DCM in the cervical spine and the recent proposal of degenerative cervical radiculopathy(DCR), extending this common nomenclature framework to the terms degenerative spinal myelopathy and degenerative thoracic myelopathy will help improve recognition and communication.
No takes yet. Share an insight, caveat, or question.
Rujeedawa et al. (2023) conducted a systematic review in Degenerative Thoracic Myelopathy. Degenerative Thoracic Myelopathy was evaluated. Degenerative thoracic myelopathy encompasses interrelated clinical entities that present similarly, supporting the adoption of a unified nomenclature framework to improve recognition and research.
Synapse has enriched 10 related papers. Consider them for comparative context: